NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 80 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q2 2014. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $116,000 | -13.4% | 213,755 | -7.1% | 0.00% | – |
| Q2 2016 | $134,000 | -71.0% | 230,178 | -27.4% | 0.00% | – |
| Q1 2016 | $462,000 | -59.4% | 316,898 | -10.9% | 0.00% | – |
| Q4 2015 | $1,138,000 | -20.9% | 355,763 | +54.6% | 0.00% | -100.0% |
| Q3 2015 | $1,438,000 | -51.1% | 230,069 | -22.4% | 0.00% | 0.0% |
| Q2 2015 | $2,943,000 | +97.9% | 296,323 | +46.8% | 0.00% | 0.0% |
| Q1 2015 | $1,487,000 | -0.2% | 201,821 | -27.5% | 0.00% | 0.0% |
| Q4 2014 | $1,490,000 | +25.8% | 278,479 | +18.3% | 0.00% | – |
| Q3 2014 | $1,184,000 | -19.1% | 235,386 | +7.9% | 0.00% | -100.0% |
| Q2 2014 | $1,464,000 | -4.9% | 218,214 | +2.6% | 0.00% | 0.0% |
| Q1 2014 | $1,539,000 | +1141.1% | 212,660 | +545.4% | 0.00% | – |
| Q4 2013 | $124,000 | – | 32,949 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Moloney Securities Asset Management, LLC | 352,660 | $320,815 | 0.06% |
| Opus Capital Group, LLC | 60,150 | $55 | 0.01% |
| AlphaMark Advisors, LLC | 14,007 | $13 | 0.01% |
| ADVISORS MANAGEMENT GROUP INC /ADV | 10,270 | $9 | 0.00% |
| LEE DANNER & BASS INC | 20,000 | $18 | 0.00% |
| Williams Jones Wealth Management, LLC. | 44,000 | $40,027 | 0.00% |
| MAI Capital Management | 20,000 | $18,194 | 0.00% |
| Bartlett & Co. LLC | 4,292 | $4 | 0.00% |
| Coston, McIsaac & Partners | 1,000 | $0 | 0.00% |